Press Release
Wyoming Trade School and Its Alumni Success Work to Banish the Fable of Blue-Collar Worthiness
WyoTech and its successful graduates are bulldozing old perceptions with world-class awards, recognitions, and sought-after career opportunities. The new model of education in America is here, and WyoTech is leading the way in partnership with their alumni and booming job market for tradespeople. Read More
Press Release
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)
The Sustainable Green Team ($SGTM), with Kevin Harrington, "Original Shark Tank" Investor, and CEO Tony Raynor, Features Sponsor with Full Interview Link. Plus, the Debut of the New Roadzen $RDZN TV Commercial Read More
Press Release
Intelligent Waves' Shadow, an Autonomous Penetration Testing Cyber-Defense Solution, Awarded Best Industry Solution in the 2025 Cybersecurity Annual Awards
Intelligent Waves (IW), a leading tech integrator that delivers mission-focused multi-domain operational expertise and innovation to the Government through high-impact technology solutions, today announced that Shadow, its autonomous pen-testing solution, was recognized as the Best National Cyber Defense industry solution in 2025 Cybersecurity Annual Awards Competition. Read More
Press Release
Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
Clinical response rate of 63.5% and clinical remission rate of 30.2% achieved at Week 12 with the highest dose, which continued to improve through Week 28 All three doses met the primary endpoint of clinical response at Week 12, with a favorable safety profile These results in ulcerative colitis build on strong data recently reported for the plaque psoriasis Phase 3 program Read More
Press Release
Electrovaya Secures $20M Credit Facility from Bank of Montreal to Accelerate Growth and Reduce Costs
Three year term includes an accordion of US$5.0 million expansion option to fuel future growth Lower-cost facility replaces existing debt, reducing servicing costs Supports operations in both the United States and Canada and enables financing from the United States Export-Import Bank ("EXIM") for Jamestown manufacturing investments Read More
Press Release
Electrovaya Closes $50.8 Million Direct Loan with Export-Import Bank of the United States (“EXIM”) to Expand U.S. Battery Manufacturing
Funding Under EXIM‘s Make More in America Initiative to Fuel Expansion of Electrovaya's Jamestown Battery Manufacturing Facility Combination of EXIM Funding with $20 million BMO Credit Facility and $12 Million Equity Capital from December 2024 Provides Electrovaya with Over $80 million for Aggressive U.S. Expansion Electrovaya has Met Substantially All Condition Precedent Requirements to Drawdown on the EXIM Facility Read More
Press Release
Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study Topline results from Phase 3 ICONIC-ADVANCE 1&2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe PsO Results pave the way to initiate the first-ever head-to-head study (ICONIC-ASCEND) seeking to demonstrate the superiority of a pill versus injectable biologic in moderate-to-severe PsO Read More
Press Release